Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance).

Blood advances·2026
Same author

Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis.

Annals of hematology·2025
Same author

Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.

British journal of haematology·2025
Same author

Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.

JCO oncology practice·2025
Same author

Combined next generation sequencing for HLA typing and chimerism testing.

Human immunology·2025
Same author

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.

Cancer immunology, immunotherapy : CII·2025

相关实验视频

Updated: Jul 26, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.2K

在预测白血病复发时,使用增加混合化学的测试测试的敏感性和特异性.

Ruoheng Zhang1, Yimeng Shang2, Joseph Cioccio1

  • 1Penn State Cancer Institute, Hershey, Pennsylvania.

The Journal of molecular diagnostics : JMD
|November 27, 2024
PubMed
概括

基因组测试有效地预测干细胞移植后白血病复发. 越来越多的混合奇默症 (IMC) 表明疾病活性,但假阳性/假阴性需要仔细解释,以准确监测白血病.

更多相关视频

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.3K
Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates
05:53

Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates

Published on: May 29, 2018

10.2K

相关实验视频

Last Updated: Jul 26, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.2K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.3K
Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates
05:53

Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates

Published on: May 29, 2018

10.2K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 移植医学 移植医学 移植医学

背景情况:

  • 干细胞移植是血液恶性瘤的治疗选择.
  • 移植后监测嵌合症对于检测复发至关重要.
  • 越来越多的混合嵌合体 (IMC) 是疾病复发的早期指标.

研究的目的:

  • 评估针对白血病复发的奇默症测试的预测价值.
  • 为了评估增加混合嵌合体 (IMC) 作为疾病活动的替代品的性能.
  • 分析嵌合体监测在预测干细胞移植后复发的敏感性和特异性.

主要方法:

  • 量化PCR和短串重复方法被结合起来进行高灵敏度嵌合体分析.
  • 研究了一组184名为白血病 (AML,ALL,MDS) 进行干细胞移植的患者.
  • 进行了2389个模拟性测试,平均随访时间为1054天.

主要成果:

  • 在一次IMC (HR 9.9) 或两个或两个以上连续的IMC (HR 44.4) 后,观察到复发风险显著增加.
  • 在IMC后30天预测的复发概率为0% (没有IMC),10% (一个IMC) 和40% (≥2个IMC).
  • 化学反应监测显示,复发预测的灵敏度为86.4%,特异性为91.6%,错误阳性 (T细胞污染) 和错误阴性 (快速复发,外围复发) 的原因已确定.

结论:

  • 化学反应监测是预测干细胞移植后白血病复发的宝贵工具.
  • 解释IMC需要谨慎,因为潜在的假阳性和假阴性.
  • 删除T细胞的策略可以增强混合T细胞奇默症患者的奇默症测试的特异性.